FDA Panel Votes For Pneumonia Antibiotic Approval
An advisory committee for the U.S. Food and Drug Administration on Friday voted by a slim margin that an experimental antibiotic drug developed to treat the most common type of pneumonia...To view the full article, register now.
Already a subscriber? Click here to view full article